다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Spero Therapeutics Inc (SPRO)
Spero Therapeutics Inc (SPRO) 뉴스

SPRO

Spero Therapeutics (SPRO)

Spero Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SPRO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/06	22:05	GlobeNewswire Inc.	Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024	NASDAQ:SPRO	Spero Therapeutics Inc
2024/02/28	22:05	GlobeNewswire Inc.	Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections	NASDAQ:SPRO	Spero Therapeutics Inc
2024/02/26	22:05	GlobeNewswire Inc.	Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference	NASDAQ:SPRO	Spero Therapeutics Inc
2024/02/10	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SPRO	Spero Therapeutics Inc
2024/02/06	10:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRO	Spero Therapeutics Inc
2024/02/06	10:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRO	Spero Therapeutics Inc
2024/02/06	10:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRO	Spero Therapeutics Inc
2024/02/06	10:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRO	Spero Therapeutics Inc
2024/02/06	10:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRO	Spero Therapeutics Inc
2024/02/06	06:50	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SPRO	Spero Therapeutics Inc
2024/02/01	06:05	GlobeNewswire Inc.	Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:SPRO	Spero Therapeutics Inc
2024/01/08	20:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SPRO	Spero Therapeutics Inc
2024/01/05	22:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SPRO	Spero Therapeutics Inc
2024/01/05	22:05	GlobeNewswire Inc.	Spero Therapeutics Provides Corporate Update and 2024 Outlook	NASDAQ:SPRO	Spero Therapeutics Inc
2024/01/05	06:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRO	Spero Therapeutics Inc
2024/01/02	22:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SPRO	Spero Therapeutics Inc
2024/01/02	22:05	GlobeNewswire Inc.	Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/16	06:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/16	06:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/14	06:50	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/14	06:45	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/14	06:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/14	06:05	GlobeNewswire Inc.	Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/14	06:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/13	20:45	IH Market News	Monday’s Wall Street Highlights: Boeing, Novo Nordisk, Moody’s, StoneCo, and more	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/06	22:05	GlobeNewswire Inc.	Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/02	05:05	GlobeNewswire Inc.	Spero Therapeutics to Present at Upcoming November Investor Conferences	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/01	21:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/01	21:05	GlobeNewswire Inc.	Spero Therapeutics Appoints Esther Rajavelu as Chief Financial Officer and Chief Business Officer	NASDAQ:SPRO	Spero Therapeutics Inc
2023/11/01	05:05	GlobeNewswire Inc.	Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:SPRO	Spero Therapeutics Inc

검색 관련기사 보기:NASDAQ:SPRO

1 2 3 4 5 6 7 8 9 10 다음 >>

US Dollar vs Yen

Deutsche Telekom (QX)

Verizon Communications

American Express

US Dollar vs Sterling

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관